6.0588
price up icon13.67%   0.7288
 
loading
전일 마감가:
$5.33
열려 있는:
$6
하루 거래량:
43,157
Relative Volume:
0.21
시가총액:
$113.04M
수익:
$264.74M
순이익/손실:
$-49.71M
주가수익비율:
-10.63
EPS:
-0.57
순현금흐름:
$-43.55M
1주 성능:
-36.95%
1개월 성능:
-44.41%
6개월 성능:
+62.87%
1년 성능:
-25.77%
1일 변동 폭
Value
$5.66
$6.47
1주일 범위
Value
$5.15
$9.99
52주 변동 폭
Value
$0.3901
$87.50

Calamp Corp Stock (CAMP) Company Profile

Name
명칭
Calamp Corp
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
@calamp
Name
다음 수익 날짜
2024-07-25
Name
최신 SEC 제출 서류
Name
CAMP's Discussions on Twitter

CAMP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
CAMP 6.0588 113.04M 264.74M -49.71M -43.55M -0.57
VRTX 450.00 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.18 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.92 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.91 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.24 24.89B 3.30B -501.07M 1.03B 11.54

Calamp Corp Stock (CAMP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-08-16 업그레이드 Craig Hallum Hold → Buy
2021-12-22 다운그레이드 Craig Hallum Buy → Hold
2021-09-24 재확인 Craig Hallum Buy
2021-06-25 재확인 Craig Hallum Buy
2020-12-18 다운그레이드 JP Morgan Neutral → Underweight
2020-04-17 업그레이드 Jefferies Hold → Buy
2020-03-05 재확인 Craig Hallum Buy
2019-12-20 재확인 Craig Hallum Buy
2019-12-20 다운그레이드 First Analysis Sec Outperform → Neutral
2019-06-28 업그레이드 Northland Capital Market Perform → Outperform
2019-05-29 다운그레이드 Goldman Neutral → Sell
2019-05-01 재확인 Craig Hallum Buy
2019-03-25 다운그레이드 JP Morgan Overweight → Neutral
2019-01-25 업그레이드 JP Morgan Neutral → Overweight
2018-12-21 업그레이드 Craig Hallum Hold → Buy
2018-12-14 재확인 B. Riley FBR Buy
2018-12-11 다운그레이드 First Analysis Sec Strong Buy → Outperform
2018-12-11 다운그레이드 Northland Capital Outperform → Market Perform
2018-11-27 개시 Goldman Neutral
2018-10-15 개시 Jefferies Hold
2018-09-28 재확인 Craig Hallum Hold
2018-04-27 재확인 Craig Hallum Hold
2018-03-08 다운그레이드 Craig Hallum Buy → Hold
2018-02-16 업그레이드 First Analysis Sec Equal-Weight → Overweight
모두보기

Calamp Corp 주식(CAMP)의 최신 뉴스

pulisher
Nov 20, 2024

CalAmp Files Bankruptcy to Complete Debt Restructuring - MSN

Nov 20, 2024
pulisher
Nov 08, 2024

William Blair Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform Recommendation - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

October IPOs in Biotech, Cleantech, Transportation, Retail and Homebuilder Sectors - Investorideas.com newswire

Nov 08, 2024
pulisher
Nov 06, 2024

Camp4 Therapeutics initiated with an Overweight at Piper Sandler - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

JP Morgan Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight Recommendation - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

JPMorgan sees "breakthrough potential" in CAMP4 stock, bets big on RNA tech - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

CAMP4 Analyst Highlights Rare Disease Platform Potential - Benzinga

Nov 05, 2024
pulisher
Nov 05, 2024

Camp4 gains after earning bullish views on Street - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Camp4 stock gains after earning bullish views (CAMP:NASDAQ) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

William Blair upbeat on CAMP4 shares with Outperform rating - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

William Blair upbeat on CAMP4 shares with Outperform rating By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Leerink sets stock target for CAMP4, cites broad UCD treatment potential - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Piper Sandler optimistic on CAMP4 stock, cites potential in pioneering RNA technology - Investing.com

Nov 05, 2024
pulisher
Oct 25, 2024

Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline

Oct 25, 2024
pulisher
Oct 25, 2024

Internet of Things (IoT) in Construction Market Worth Over $61.7 Billion by 2030Industry Analysis and Forecast with Profiles of 37 Major Companies Including Autodesk, Calamp Corp, Caterpillar, Dronedeploy - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN

Oct 25, 2024
pulisher
Oct 20, 2024

Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.

Oct 20, 2024
pulisher
Oct 18, 2024

Camp4 Therapeutics sees $8.4 million stock purchase by Northpond Ventures - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

Camp4 Therapeutics sees $7.99m stock purchase by investors By Investing.com - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

CAMP4 Rings the Opening Bell - Nasdaq

Oct 18, 2024
pulisher
Oct 16, 2024

Insider Trading Activity Tuesday: Top Buys and Sells in US Stocks Revealed - Investing.com

Oct 16, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics sees $9.99 million stock purchase by Polaris - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics sees $9.99 million stock purchase by 5AM Ventures - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Nashat Amir buys $9.99m in stock - Investing.com India

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Nashat Amir buys $9.99m in stock By Investing.com - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Andrew Schwab buys $9.99m in stock - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Andrew Schwab buys $9.99m in stock By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

Upstream Bio and Camp4 and Ceribell Transactions - William Blair

Oct 15, 2024
pulisher
Oct 14, 2024

CAMP4 Therapeutics’ $75 Million IPO - Global Legal Chronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Opening Day: Another trio of biotech IPOs make Friday debut - Yahoo Finance

Oct 14, 2024
pulisher
Oct 13, 2024

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN

Oct 13, 2024
pulisher
Oct 12, 2024

CAMP4 stock edges up 2% following $75M IPO - MSN

Oct 12, 2024
pulisher
Oct 11, 2024

Upstream catches aftermarket updraft, as Camp4 IPO gets muted reception - BioCentury

Oct 11, 2024
pulisher
Oct 11, 2024

Finance Watch: 2024 Has Now Beaten 2023’s Total Of 21 IPOs - Scrip

Oct 11, 2024
pulisher
Oct 11, 2024

Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN

Oct 11, 2024
pulisher
Oct 11, 2024

6 Firms Guide IPO Trio From Biotech, Medical Device Cos. - Law360

Oct 11, 2024

Calamp Corp (CAMP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Calamp Corp 주식 (CAMP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
AH Equity Partners Bio I, L.L.
10% Owner
Oct 15 '24
Buy
11.00
727,272
7,999,992
1,579,885
Enavate Sciences GP, LLC
10% Owner
Oct 15 '24
Buy
11.00
1,363,636
14,999,996
3,785,802
Polaris Management Co. VII, L.
10% Owner
Oct 15 '24
Buy
11.00
909,090
9,999,990
909,090
5AM Partners VI, LLC
10% Owner
Oct 15 '24
Buy
11.00
909,090
9,999,990
2,625,145
Nashat Amir
Director
Oct 15 '24
Buy
11.00
909,090
9,999,990
909,090
Schwab Andrew J.
Director
Oct 15 '24
Buy
11.00
909,090
9,999,990
2,625,145
Cohenour Jason
Director
Jun 05 '24
Sale
0.83
8,640
7,176
0
Cohenour Jason
Director
Mar 05 '24
Option Exercise
0.00
7,824
0
10,962
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):